The healthcare industry has remained robust throughout the economic downturn and is one of the fastest growing markets in the world. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is also confident in India’s pharmaceutical industry growth opportunities and is looking to continue strengthening its relationship with other countries for export, by preparing to participate at Arab Health 2013. It is organised by Informa Life Sciences Exhibitions, takes place from 28-31 January 2013 at the Dubai International Convention and Exhibition Centre. With more than 3500 exhibiting companies from 32 countries, and 18 CME accredited medical conferences, Arab Health is a much anticipated addition to the 2013 medical event calendar in the Middle East and subcontinent region.
Arab Health Exhibition provides a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and subcontinent.
Today, India’s pharmaceutical industry is known as the “Global pharmacy of the world”. India offers almost every product which has gone off patent and is a global market leader in the export of generic drugs to countries such as the United States and Japan, as well as to countries in Africa and Europe.
Indian firms manufactured products for nearly 60,000 generic brands, covering 60 key therapeutic areas. Approximately 80 per cent of this domestic production consisted of formulations, while the remaining 20 per cent comprised bulk drugs. India accounts for almost 10 per cent of global drug production by volume and is increasingly focusing on indigenous R&D. There are about 3,000 pharmaceutical manufacturers, with over 10,500 units, the vast majority of which focus on generic drugs. India is home to 250 large manufacturers, and the domestic drug industry employs a workforce of approximately 460,000 people.
Representing Pharmexcil at Arab Health 2013 Dr PV Appaji, Director General, Pharmaceuticals Export Promotions Council of India said, “Amid global economic concerns, the Indian pharma industry is bullish with a steep growth target. Within the pharma sector, India is one of the top five generic exporters of the world and maintains a positive trade balance. This is the seventh year for the council to take part at the prestigious Arab Health event. Indian companies are very aware of the market potential in the Middle East and they will showcase a unique variety of high-tech and innovative products, aiming to expand their business in the Middle East region.”
Companies such as Ascent Healthcare, Adroit Manufacturing Co, Dr Surgicals, Lab Care Diagnostics (I), and approximately 70 other healthcare and pharmaceutical companies from India will be exhibiting at Arab Health this year.
Simon Page, Managing Director, Informa Life Sciences Exhibitions, “As a global exhibitions organiser, we are seeing very buoyant growth in emerging market territories where trade shows continue to be a major source of buyer and seller interaction. Multinationals are expected to expand extensively into the Indian pharma markets – by as high as 60.0 per cent by 2015 through acquisitions, which will gradually enable the Indian companies to gain a foothold in the Western regulated markets.
Arab Health 2013 is one of the major International exhibitions for surgical, hospital, medical equipment and pharma. It offers important opportunities to build relations within the industry, to showcase progress and achievement in the field and to explore new opportunities with stakeholders in the healthcare field. This year more than 200 new exhibitors will bring the total to almost 3500 from 63 countries across the globe.
The trade show is followed by The Arab Heath Innovation and Achievement Awards which continues to draw hundreds of nominations from healthcare facilities and individuals across the region. The 2013 Arab Health Awards ceremony will take place on 29 January in Dubai, UAE.
EP News Bureau – Mumbai